Saundra Pelletier

Saundra Pelletier is the CEO of Evofem Biosciences, where significant achievements include launching Phexxi, the first hormone-free, on-demand birth control approved in the U.S., and leading the company's transition to the public market with over $500 million in equity financing. Pelletier also serves as a Director at Windtree Therapeutics, Inc., a biotechnology company, and is an active member of the Women Corporate Directors Foundation and the Advisory Council for Girls Inc. of San Diego County. Previous roles include Director at TRACON Pharmaceuticals and Women Deliver, and founding CEO of WCG Cares, where a focus on women's reproductive health led to the launch of products across over 100 countries. Pelletier has provided consulting and coaching to major pharmaceutical companies and holds an honorary Doctor of Business Administration from Husson University, in addition to bachelor's degrees in Business Administration and Communications from Husson University and the New England School of Communications, respectively.